Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Credit agrmnt [a]
CC transcript
Asset disposition
Acq. announced
Director departure
Appointed COO
Orthofix Medical Inc. (OFIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/08/2023 8-K Investor presentation, Quarterly results
Docs: "Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance • Net sales of $187.0 million, an increase of 58% on a reported basis and 7% on a pro forma constant currency basis over prior year • Bone Growth Therapies growth of 10%, marking two consecutive quarters with double-digit net sales increases, with growth coming from both spine and fracture commercial channels • U.S. spinal implants, biologics, and enabling technologies sales up 7% over prior year on a pro forma basis, driven by new distribution and product innovation • Global Orthopedics net sales increase of 6% on a reported basis and 5% on a constant currency basis over prior year • Announced full commercial launch of the following products: o WaveForm® A interb...",
"Corporate Investor Deck August 2023 Forward Looking Statements This"
05/09/2023 8-K Quarterly results
Docs: "Orthofix Reports First Quarter 2023 Results • Net sales of $175.2 million, an increase of 65% on a reported basis and 12% on a pro forma constant currency basis over prior year • Bone Growth Therapies growth of 14%, with growth coming from both spine and fracture commercial channels • U.S. spinal implant sales up 18% over prior year on a pro forma basis, driven by new distribution and product innovation • Continued double-digit growth in Global Orthopedics over prior year on a constant currency basis • Announced the full commercial launch of the Lattus™ Lateral Access System and the Fathom™ Pedicle-Based Retractor System, which addresses an estimated $1.8 billion market related to minimally invasive spine procedures"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 8-K Quarterly results
Docs: "Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results LEWISVILLE, Texas — March 6, 2023 — The merger of Orthofix Medical Inc. and SeaSpine Holdings Corporation became effective as of January 5, 2023. This news release includes the financial results of stand-alone Orthofix and stand-alone SeaSpine for the fourth quarter and full year ended December 31, 2022. As such, these financial results do not include any potential accounting adjustments the merger may have on future net sales or operating results. Orthofix Fourth Quarter Highlights • Net sales of $122.2 million, a decrease of 2% on a reported basis and flat on a constant currency basis over prior year • Bone Growth Therapies net sales growth of approximately 3%, driven by the commercial ..."
01/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results LEWISVILLE, Texas — January 9, 2023 — The merger of equals between Orthofix Medical Inc. and SeaSpine Holdings Corporation became effective as of January 5, 2023. This news release includes the pre-merger unaudited preliminary net sales results of stand-alone SeaSpine and stand-alone Orthofix for the fourth quarter and full year ended December 31, 2022. As such, these preliminary financial results do not include any potential accounting adjustments that the merger may have on future net sales results. SeaSpine Fourth Quarter Highlights • Net sales of $63.2 - $63.7 million, an increase of more than 13% on a reported basis over prior year and an increase of more than 1..."
01/05/2023 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Fina...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Indemnification Agreement between Orthofix Medical Inc. and its directors and officers",
"Offer Letter between the Company and Keith C. Valentine",
"Offer Letter between the Company and John J. Bostjancic",
"Offer Letter between the Company and Patrick L. Keran",
"Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company"
01/04/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
12/27/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
12/05/2022 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/18/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing"
11/03/2022 8-K Quarterly results
10/11/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results"
10/11/2022 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agreement and Plan of Merger, by and among Orthofix Medical Inc., Orca Merger Sub Inc. and SeaSpine Holdings Corporation",
"Amended and Restated Bylaws of Orthofix Medical Inc",
"Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company"
08/05/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
04/08/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Orthofix Announces New Business Unit President Kimberley Elting, Chief Legal and Development Officer for Orthofix, Appointed to Lead Global Orthopedics Business"
02/25/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results"
12/14/2021 8-K Quarterly results
11/05/2021 8-K Quarterly results
Docs: "Orthofix Reports Third Quarter 2021 Results"
09/29/2021 8-K Quarterly results
09/23/2021 8-K Quarterly results
08/06/2021 8-K Quarterly results
Docs: "Orthofix Reports Second Quarter 2021 Results"
07/06/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/21/2021 8-K Quarterly results
04/30/2021 8-K Quarterly results
04/07/2021 8-K Quarterly results
02/26/2021 8-K Quarterly results
01/29/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Bylaws, as amended"
01/12/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Net sales of $111.0 million, an increase of 52% sequentially and within 2% of our 2019 performance • US Spinal Implants third quarter net sales increased 19% over the prior year • Motion Preservation sales in the U.S. of $5.2 million, an increase of 44% sequentially and over 400% over prior year • Entered into an investment and co-development partnership with Neo Medical SA"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy